In this issue:
ATG vs. PTCy as acute GVHD prophylaxis in allogeneic SCT
Comparative efficacies of drug therapies used for ITP
Oral azacitidine prolongs survival in AML in remission independently of MRD
Haematological malignancies magnify impact of BMI on insulin resistance in cancer survivors
First-line azacitidine ±durvalumab for higher-risk MDS
Apixaban vs. warfarin for thrombosis prevention in thrombotic antiphospholipid syndrome
Deferasirox for managing iron overload in ruxolitinib-treated myelofibrosis
Midostaurin for advanced systemic mastocytosis
Doxycycline for recurrent epistaxis
Preventing thrombosis in PAD after lower-extremity revascularisation
Please login below to download this issue (PDF)